The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

Aug. 30, 2018
Applicant:

Jeju National University Industry-academic Cooperation Foundation, Jeju-si, KR;

Inventors:

You-Jin Jeon, Jeju-si, KR;

Jae-Young Oh, Jeju-si, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A23L 33/18 (2016.01); A23L 17/20 (2016.01); A23L 17/00 (2016.01); A61K 38/08 (2019.01); A61K 38/00 (2006.01); C07K 7/06 (2006.01); A61K 38/01 (2006.01); A23L 27/40 (2016.01); A61P 39/06 (2006.01); A61P 9/12 (2006.01); A61K 38/48 (2006.01); C07K 1/12 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1706 (2013.01); A23L 17/20 (2016.08); A23L 17/70 (2016.08); A23L 27/40 (2016.08); A23L 33/18 (2016.08); A61K 38/08 (2013.01); A61K 38/488 (2013.01); A61K 38/4826 (2013.01); A61P 9/12 (2018.01); A61P 39/06 (2018.01); A23V 2002/00 (2013.01); A61K 38/00 (2013.01); A61K 38/01 (2013.01); C07K 1/12 (2013.01); C07K 7/06 (2013.01);
Abstract

Disclosed is a pharmaceutical composition or food composition for the treatment or prevention of hypertension, containing a peptide isolated from a fraction of a flounder surimi hydrolysate as an active ingredient and is based on the finding that the flounder surimi has an effect of reducing blood pressure, and the hydrolysate of the flounder surimi, the fraction of the hydrolysate of the flounder surimi and peptides isolated from the fraction of the hydrolysate of the flounder surimi have an inhibition activity against an angiotensin I converting enzyme (ACE). Thus, peptides isolated from the fraction of the hydrolysate of the flounder surimi can be used for pharmaceutical compositions or food compositions for treating or preventing hypertension. Also, the present invention is based on the finding that the hydrolysate of the flounder surimi and peptides isolated therefrom have radical scavenging effect and a protective effect against oxidative stress and are thus capable of inhibiting ROS production, lipid peroxidation and apoptosis. Accordingly, peptides isolated from fractions of the hydrolysate of the flounder surimi can be used for food compositions for antioxidation.


Find Patent Forward Citations

Loading…